Search results

Order by most recent / most popular / relevance

Results: 1-10 of 18

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

A new front in the patent wars: CJEU asked for guidance on limits to injunctive relief

McDermott Will & Emery
-
European Union, USA
-
April 11 2013

The patent wars between large technology companies continue unabated. The Court of Justice of the European Union (CJEU) is set to provide guidance on

Overview of patent-statutory subject matter in biotechnology

CCPIT Patent & Trademark Law Office
-
China, European Union, Japan, USA
-
April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

Don't snag your deals on traps laid for trolls

Edwards Wildman Palmer LLP
-
European Union, USA
-
March 26 2013

The issue of non-practicing entities has been back in the news again recently. During a Google hangout last week, President Barack Obama used strong

Patent claims for ‘personalised medicines’

Mewburn Ellis LLP
-
European Union, USA
-
February 7 2013

As previously reported the US Supreme Court, in Mayo v. Prometheus, recently invalidated Prometheus's diagnostic claims - directed to a method of

Apple vs Samsung: the long war

William Fry
-
European Union, USA
-
December 21 2012

Apple has lost its appeal to ban the sale of 26 patent infringing Samsung devices in the US after it failed to establish that these Samsung

Agreeing to license standard-essential patents on RAND terms may bar foreign injunctive relief

McDermott Will & Emery
-
European Union, Germany, USA
-
October 31 2012

Addressing an anti-suit injunction in the context of patent licensing, the U.S. Court of Appeals for the Ninth Circuit affirmed a preliminary injunction issued by a district court temporarily enjoining the enforcement of a German patent injunction

European Commission ups the cost of paying for delay

King & Wood Mallesons
-
Australia, European Union, USA
-
August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

General counsel update

Herbert Smith Freehills LLP
-
China, European Union, Germany, Hong Kong, Indonesia, Mongolia, Singapore, United Kingdom, USA
-
July 11 2012

This is the thirtieth in our series of general counsel updates which aim to summarise major developments in key areas

next >

Search results

IP challenges for the personalised medicines industry - gene claims (part 1)

Dispelling the Myriad gene patent harmonization myth

A new front in the patent wars: CJEU asked for guidance on limits to injunctive relief

Overview of patent-statutory subject matter in biotechnology

Don't snag your deals on traps laid for trolls

Patent claims for ‘personalised medicines’

Apple vs Samsung: the long war

Agreeing to license standard-essential patents on RAND terms may bar foreign injunctive relief

European Commission ups the cost of paying for delay

General counsel update

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea